We are pleased to announce that the International Society of Clinical and Molecular Epigenetics (isMOCLEP) has entered into a partnership with The Epigenetics Society (ES).
Professor Melanie Ehrlich, CEO of Epigenetics Society:
The collaboration between isMOCLEP and the Epigenetics Society (ES) offers opportunities for encouraging co-membership in both societies, coordinating conferences so that their timing does not conflict, and engaging in joint projects. One of these projects, which has just begun its planning stage, is outreach to the non-scientist public about the meaning and importance of epigenetics and its practical applications.
Professor Tomasz K. Wojdacz, CEO of isMOCLEP:
One of the main goals of the isMOCLEP is to consolidate epigenetic research world wide. The agreement with the Epigenetics Society is the first step towards that goal. We are looking forward to this collaboration and our joint projects that will aim to consolidate the epigenetic community and create a platform to facilitate excellent epigenetic research across Atlantic.
Comments